|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | |
| A61K 47/61 | |||
| A61K 47/69 | |||
| A61P 3/10 |
| (11) | Number of the document | 3302567 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16727469.5 |
| Date of filing the European patent application | 2016-06-02 | |
| (97) | Date of publication of the European application | 2018-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/062496 |
| Date | 2016-06-02 |
| (87) | Number | WO 2016/193371 |
| Date | 2016-12-08 |
| (30) | Number | Date | Country code |
| 15305858 | 2015-06-05 | EP |
| (72) |
KADEREIT, Dieter, DE
WAGNER, Michael, DE
OLPP, Thomas, DE
MEYER, Nino, DE
DHAL, Pradeep, US
KONOWICZ, Paul, US
MILLER, Robert, US
STEFANO, James, US
BESEV, Magnus, US
BOSSART, Martin, DE
LORENZ, Katrin, DE
HAACK, Torsten, DE
EVERS, Andreas, DE
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | PRODRUGS COMPRISING AN GLP-1/GLUCAGON DUAL AGONIST LINKER HYALURONIC ACID CONJUGATE |
| PRODRUGS COMPRISING AN GLP-1/GLUCAGON DUAL AGONIST LINKER HYALURONIC ACID CONJUGATE |